Abstract
Tendency to hypercoagulation is a common phenomenon in primary osteoarthritis patients (POA) undergoing total knee arthroplasty (TKA) surgery, but the clinical implications of this condition are not clear. Therefore we aimed to evaluate the inflammatory and coagulation parameters in the patient group and find a possible explanation for the tendency to hypercoagulation occurring in plasma and synovia of inflamed joints. Of the evaluated factors involved in inflammation and coagulation, galectin-3, C reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, FVIIa:C, FXII:C, and platelet count increased, whereas tissue factor (TF) activity in synovia, PT, APTT and FVII:C in plasma and synovia were decreased. In conclusion, activation of inflammation and tendency to hypercoagulation is observed in preoperative plasma and synovia of patients undergoing TKA surgery.
Similar content being viewed by others
References
Mukoba, Y., and M. Kawamata. 2004. Perioperative hypercoagulability in patient with rheumatoid arthritis. J. Anesth. 18:62–64. doi:10.1007/s00540-003-0206-4
Craven, S., L. Dewar, X. Yang, J. Ginsberg, and F. A. Ofosu. 2007. Altered regulation of in vivo coagulation in orthopedic patients prior to knee or hip replacement surgery. Blood Coagul. Fibrinolysis 18:219–225. doi:10.1097/01.mbc.0000264704.90039.5d.
Szaba, F. M., and S. T. Smiley. 2002. Role for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99:1053–1059. doi:10.1182/blood.V99.3.1053.
Brice-Weinberg, J., A. M. M. Pippen, and C. S. Greenberg. 1991. Extravascular fibrin formatiıon and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 34:996–1005. doi:10.1002/art.1780340809.
Sánchez-Pernaute, O., M. J. López-Armada, E. Calvo, I. Díez-Ortego, R. Largo, J. Egido, and G. Herrero-Beaumont. 2003. Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis. Rheumatology (Oxford) 42:19–25. doi:10.1093/rheumatology/keg021.
So, A. K., P. A. Varisco, B. Kemkes-Matthes, H. Morard, V. Chobaz-Peclat, J. C. Gerster, and N. Busso. 2003. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis. J. Thromb. Haemost. 1:2510–2515. doi:10.1111/j.1538-7836.2003.00462.x.
Almkvist, J., and A. Karlsson. 2004. Galectins as inflammatory mediators. Glycoconj. J. 19:575–581. doi:10.1023/B:GLYC.0000014088.21242.e0.
Liu, F. T., D. K. Hsu, R. I. Zuberi, I. Kuwabara, E. Y. Chi, and W. R. Henderson. 1995. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147:1016–1028.
Fernández, G. C., J. M. Ilarregui, C. J. Rubel, M. A. Toscano, S. A. Gómez, M. Beigier-Bompadre, M. A. Isturiz, G. A. Rabinovich, and M. S. Palermo. 2005. Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology 15:519–127. doi:10.1093/glycob/cwi026.
Nieminen, J., C. St-Pierre, and S. Sato. 2005. Galectin-3 interacts with native and primed neutrophils, inducing innate immune responses. J. Leukoc. Biol. 78:1127–1135.
Ohshima, S., S. Kuchen, C. A. Seemayer, D. Kyburz, A. Hirt, S. Klinzing, B. A. Michel, R. E. Gay, F. T. Liu, S. Gay, and M. Neidhart. 2003. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis. Rheum. 48:2788–2795. doi:10.1002/art.11287.
Adams, R. A., C. Schachtrup, D. Davalos, I. Tsigelny, and K. Akassoglu. 2007. Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr. Med. Chem. 14:2925–2936. doi:10.2174/092986707782360015.
Bare, J., S. J. MacDonald, and R. B. Bourne. 2006. Preoperative evaluations in revision total knee arthroplasty. Clin. Orthop. Relat. Res. 446:40–44. doi:10.1097/01.blo.0000218727.14097.d5.
Busso, N., C. Morard, R. Salvi, V. Peclat, and A. So. 2003. Role of the tissue factor pathway in synovial inflammation. Arthritis Rheum. 48:651–659. doi:10.1002/art.10869.
Bokarewa, M. I., J. Morrissey, and A. Tarkowski. 2002. Intra-articular tissue factor/factor VII complex induces chronic arthritis. Inflamm. Res. 51:471–477. doi:10.1007/PL00012414.
Cermak, J., N. S. Key, R. R. Bach, J. Balla, H. S. Jacob, and G. M. Vercellotti. 1993. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513–520.
Day, S. M., J. I. Reeve, B. Pedersen, D. M. Farris, D. D. Myers, M. Im, T. W. Wakelfield, N. Mackman, and W. P. Fay. 2005. Macrovascular thrombosis in driven by tissue factor derived primarily from the blood vessel wall. Blood 105:192–198. doi:10.1182/blood-2004-06-2225.
Norris, L. A. 2003. Blood coagulation. Best. Pract. Res. Clin. Obstet. Gynaecol. 17:369–383. doi:10.1016/S1521-6934(03)00014-2.
Mitropoulos, K. A. 1999. High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro. Thromb Res. 94:117–129. doi:10.1016/S0049-3848(98)00207-2.
Renné, T., B. Nieswandt, and D. Gailani. 2006. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol. Dis. 36:148–151. doi:10.1016/j.bcmd.2005.12.014.
Basaj, S. P., and H. Joist. 1999. New insight into how blood clots:Implications for the use of APTT and PT as coagulation screening test and in monitoring of anticoagulant therapy. Semin. Thromb Hemost. 25:407–417.
Iturbe, T., R. Cornudella, R. de Miguel, T. Olave, J. A. Moreno, and M. Gutierrez. 1999. Existence of a hypercoagulabalitiy state prior to prosthetic hip or knee surgery. Haematologica 84:87–88. doi:10.1159/000015221.
Altman, R., E. Asch, D. Bloch, D. Bole, K. Borenstein, and K. Brandt. 1986. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 29:1039–1049. doi:10.1002/art.1780290816.
Marklund, S. L., A. Bjelle, and L. G. Elmqvist. 1986. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann. Rheum. Dis. 45:847–851. doi:10.1136/ard.45.10.847.
Kaur, H., and B. Halliwell. 1994. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:9–12. doi:10.1016/0014-5793(94)00722-5.
Gambino, S. R., J. J. Dire, M. Monteleon, and D. C. Budd. 1965. The Westergren sedimentation rate using K3 EDTA. Am. J. Clin. Pathol. 43:173–177.
Alturfan, A. A., E. E. Alturfan, N. Dariyerli, E. Zengin, E. Aytac, G. Yigit, and E. Kokoglu. 2006. Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism. Endocrine 30:63–67. doi:10.1385/ENDO:30:1:63.
Vray, B., I. Camby, V. Vercruysse, T. Mijatovic, N. V. Bovin, P. Ricciardi-Castagnoli, H. Kaltner, I. Salmon, and H. J. K. R. Gabius. 2004. Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 14:647–657. doi:10.1093/glycob/cwh068.
Della Valle, C. J., S. M. Sporer, J. J. Jacobs, R. A. Berger, A. G. Rosenberg, and W. G. Paprosky. 2007. Preoperative testing for sepsis before revision total knee arthroplasty. J. Arthroplasty 22:90–93. doi:10.1016/j.arth.2007.04.013.
Shou, J., C. M. Bull, L. Li, H. R. Qian, T. Wei, S. Luo, D. Perkins, P. J. Solenberg, S. L. Tan, X. Y. Chen, N. W. Roehm, J. A. Wolos, and J. E. Onyia. 2006. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res. Ther. 8:28–31. doi:10.1186/ar1883.
Neidhart, M., F. Zaucke, R. von Knoch, A. Jüngel, B. A. Michel, R. E. Gay, and S. Gay. 2005. Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann. Rheum. Dis. 64:419–424. doi:10.1136/ard.2004.023135.
Reboul, P., J. Martel-Pelletier, and J. P. Pelletier. 2004. Galectin-3 in osteoarthritis: when the fountain of youth doesn't deliver its promises. Curr. Opin. Rheumatol. 16:595–598. doi:10.1097/01.bor.0000129663.76107.d6.
Jabs, W. J., E. Theissing, M. Nitschke, J. F. Bechtel, M. Duchrow, S. Mohamed, B. Jahrbeck, H. H. Sievers, J. Steinhoff, and C. Bartels. 2003. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 108:1428–1431. doi:10.1161/01.CIR.0000092184.43176.91.
Kushner, I., and G. Feldmann. 1978. Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit. J. Exp. Med. 148:466–477. doi:10.1084/jem.148.2.466.
Macintyre, S. S., I. Kushner, and D. Samols. 1985. Secretion of C-reactive protein becomes more efficient during the course of the acute phase response. J. Biol. Chem. 260:4169–4173.
White, J., M. Kelly, and R. Dunsmuir. 1998. C reactive protein level after total hip and total knee replacement. J. Bone Joint Surg. Br. 80:909–911. doi:10.1302/0301-620X.80B5.8708.
Laiho, K., H. Mäenpää, H. Kautiainen, M. Kauppi, K. Kaarela, M. Lehto, and E. Belt. 2001. Rise in serum C reactive protein after hip and knee arthroplasties in patients with rheumatoid arthritis. Ann. Rheum. Dis. 60:275–277. doi:10.1136/ard.60.3.275.
Ropes, M. V., and W. Bauer. 1953. Synovial fluid changes in joint diseases. Harvard Press, Cambridge, MA.
Liu, X., and T. H. Piela-Smith. 2000. Fibrin(ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts. J. Immunol. 165:5255–2561.
Carmassi, F., F. de Negri, M. Morale, K. Y. Song, and S. I. Chung. 1996. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis. Semin. Thromb. Hemost. 22:489–496.
Eshkar-Sebban, L., D. Ronen, D. Levartovsky, O. Elkayam, D. Caspi, S. Aamar, H. Amital, A. Rubinow, I. Golan, D. Naor, Y. Zick, and I. Golan. 2007. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J. Immunol. 15:1225–1235.
Nakano, S., T. Ikata, I. Kinoshita, J. Kanematsu, and S. Yasuoka. 1999. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin. Exp. Rheumatol. 17:161–170.
Ribbens, C., B. Andre, O. Kaye, M. J. Kaiser, V. Bonnet, J. M. Jaspar, D. de Groote, N. Franchimont, and M. G. Malaise. 2000. Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology (Oxford) 39:1357–1365. doi:10.1093/rheumatology/39.12.1357.
Kageyama, K., Y. Nakajima, M. Shibasaki, S. Hashimoto, and T. Mizobe. 2007. Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty. J. Thromb. Haemost. 5:738–745. doi:10.1111/j.1538-7836.2007.02443.x.
Emekli-Alturfan, E., E. Kasikci, and A. Yarat. 2007. Tissue factor activities of streptozotocin induced diabetic rat tissues and the effect of peanut consumption. Diabetes Metab. Res. Rev. 23:653–658. doi:10.1002/dmrr.757.
Emekli-Alturfan, E., E. Kasikci, and A. Yarat. 2007. Peanuts improve blood glutathione, HDL-cholesterol level and change tissue factor activity in rats fed a high-cholesterol diet. Eur. J. Nutr. 46:476–482. doi:10.1007/s00394-007-0688-1.
Sambola, A., J. Osende, J. Hathcock, M. Degen, Y. Nemerson, V. Fuster, J. Crandall, and J. J. Badimon. 2003. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107:973–977. doi:10.1161/01.CIR.0000050621.67499.7D.
Schousboe, I. 2008. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation. Biochem. Pharmacol. 75:1007–1013. doi:10.1016/j.bcp.2007.10.003.
McLaren, M., J. Alkaabi, M. Connacher, J. J. Belch, and E. Valenete. 2002. Activated factor XII in rheumatoid arthritis. Rheumatol. Int. 22:182–184. doi:10.1007/s00296-002-0219-6.
Joseph, K., Y. Shibayama, B. Ghebrehiwet, and A. P. Kaplan. 2001. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin-1. Thromb Haemost. 85:119–124.
Abbink, J. J., A. M. Kamp, J. H. Nuijens, A. J. Erenberg, A. J. Swaak, and C. E. Hack. 1992. Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints. Ann. Rheum. Dis. 51:1123–1128. doi:10.1136/ard.51.10.1123.
Sodeman, W. A. 1974. Pathologic physiology-mechanisms of disease 5th edn. Saunders, Philadelphia, pp. 425–433.
Stern, S. H., and J. N. Insall. 1993. Hematologic effects of total knee arthroplasty. A prospective evaluation. Clin. Orthop. Relat. Res. 286:10–14.
Pacienza, N., R. G. Pozner, G. A. Bianco, L. P. D’Atri, D. O. Croci, S. Negrotto, E. Malaver, R. M. Gómez, G. A. Rabinovich, and M. Schattner. 2008. The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J. 22:1113–1123. doi:10.1096/fj.07-9524com.
Yang, L. C., C. J. Wang, T. H. Lee, F. C. Lin, B. Y. Yang, C. R. Lin, and T. C. Lee. 2002. Early diagnosis of deep vein thrombosis in female patients who undergo total knee arthroplasty with measurement of P-selectin activation. J. Vasc. Surg. 35:707–712. doi:10.1067/mva.2002.121852.
Ng, K. F., J. C. Lawmin, C. C. Li, S. F. Tsang, W. M. Tang, and K. Y. Chiu. 2008. Comprehensive preoperative evaluation of platelet function in total knee arthroplasty patients taking diclofenac. J. Arthroplasty 23:424–430. doi:10.1016/j.arth.2007.04.010.
Acknowledgements
We appreciate the support of Dr. Ebru Emekli-Alturfan, PhD, Marmara University, Faculty of Dentistry, Department of Biochemistry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alturfan, A.A., Eralp, L. & Emekli, N. Investigation of Inflammatory and Hemostatic Parameters in Female Patients Undergoing Total Knee Arthroplasty Surgery. Inflammation 31, 414–421 (2008). https://doi.org/10.1007/s10753-008-9093-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-008-9093-z